Neuroscience News

The Knight Initiative for Brain Resilience supports 14 high-risk, high-reward projects to advance brain health and resilience research, fostering bold research across various scientific disciplines.

Research projects funded by the Wu Tsai Neurosciences Institute's Synthetic Neuroscience Grants will advance molecular and tissue engineering tools to more precisely study and interact with brain circuits.

This week on From Our Neurons to Yours, we talk with Stanford neurologist Mike Greicius about his critique of new amyloid-clearing Alzheimer's drugs, and his optimism for the next wave of therapies currently in development.

New research by Institute affiliate Leanne Williams adds to the evidence that choosing treatment based on the neurological underpinnings of a patient’s depre

Researchers were able to see through a living mouse’s skin to its internal organs, supported in part by the Wu Tsai Neurosciences Institute, simply by applying common light-absorbing molecules.

A collaboration between Institute Faculty Scholars Julia Kaltschmidt and Todd Coleman has identified a key step in nervous system control over gut motility, opening new opportunities for understanding GI disorders in premature infants

Study in mice, supported by the Knight Initiative, suggests that an experimental cancer drug boosted brain metabolism, restored memory, and improved Alzheimer's symptoms. This novel approach may offer a new way to treat Alzheimer's beyond targeting amyloid plaques.

Sergiu Pașca has figured out how to watch the human brain develop in real time. Next up: revolutionizing psychiatry.

This week on From Our Neurons to Yours, we talk with Leanne Williams about distinctive biotypes of depression revealed by brain imaging and AI, and the implications for therapy and mental health.

The APOE4 genetic variant, carried by about 20% of people, significantly raises Alzheimer’s risk. But should we boost the gene’s potency or suppress it? A recent discovery by Knight Initiative affiliate, Mike Greicius, may provide the answers we need.

Research by Kati Andreasson and colleagues suggests that a type of drug developed for treating cancer may hold promise as a new treatment for neurodegenerati

A drug that restores brain metabolism in mouse models of Alzheimer's also improved cognitive function, according to research from the Andreasson lab.

A team of neuroscientists at the Knight Initiative for Brain Resilience have zeroed in on a critical regulator of brain metabolism that may be over-activated in the brains of patients with Alzheimer’s disease.

Institute affiliates Brad Zuchero, Justin Du Bois and colleagues discovered that neurons require signaling from glia to become fully excitable, rather than by becoming excitable by default.

It may feel like you’re being more productive, but experts like Anthony Wagner say you’re not.

Time marches on predictably, but biological aging is anything but constant, according to new research by Michael Snyder and colleagues.